Switching PMS providers can be time-taking and cumbersome, but it gets trickier if the portfolio in the red
Globally, investors are not required to go into this unnecessary hassle of a new demat account while shifting PMS advisories.
Fortrea Faces Spin-Related Challenges in the Near Term; Positive Long-Term Outlook
We reduced our fair value estimate to $15.50 per share from $27.20 to account for greater headwinds as a newly stand-alone company since its spinoff from Labcorp in 2023, which will weigh on revenue ...